LOXAPINE

Test Ligands Values Explained

Test Ligand ID - A unique identifier for the test ligand
Ligand Name - Name of the test ligand

Test Ligand ID1090
Ligand NameLOXAPINE
PubMed Compound Id3964
StructureProduct Image
Molecular FormulaC18H18ClN3O
Molecular Weight327.8
SMILESCN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
Synonymsloxapine
1977-10-2
Cloxazepine
Oxilapine
Loxapin
Dibenzacepin
Adasuve
Loxapina
Loxapinum
Hydrofluoride 3170
SUM 3170
CL-62362
Lossapina
Loxapinum [INN-Latin]
Loxapina [INN-Spanish]
Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-
SUM-3170
HF3170
HF 3170
LW 3170
Staccato loxapine
S-805
2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine
CL 62362
CHEBI:50841
CL 62,362
HSDB 3111
LER583670J
S 805
EINECS 217-835-3
2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine
BRN 0626753
Dibenz(b,f)(1,4)oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-
UNII-LER583670J
DTXSID7023229
2-Chloro-11-(4-methylpiperazino)dibenzo(b,f)(1,4)oxazepine
2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine
AZ-004
2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine
Loxapinum (INN-Latin)
Loxapina (INN-Spanish)
LOXAPINE (MART.)
LOXAPINE [MART.]
2-chloro-11-(4-methylpiperazin-1-yl)dibenzo(b,f)(1,4)oxazepine
DTXCID903229
N05AH01
217-835-3
Loxitane
Dibenzoazepine
CHEMBL831
8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine
Lossapina [DCIT]
Loxapine [USAN:INN:BAN]
Loxapine (USAN/INN)
Loxapine (water)
Loxapine (DMSO)
Adasuve (TN)
Loxapine (Standard)
Loxitane Intramuscular
Spectrum_000355
CL71,563
LOXAPINE [HSDB]
LOXAPINE [USAN]
SpecPlus_000823
8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,5]benzoxazepine
LOXAPINE [INN]
LOXAPINE [MI]
LOXAPINE [VANDF]
Prestwick0_000132
Prestwick1_000132
Prestwick2_000132
Prestwick3_000132
Spectrum2_001737
Spectrum3_001830
Spectrum5_001857
LOXAPINE [WHO-DD]
Loxitane-C Oral Suspension
Lopac0_000720
SCHEMBL94146
BSPBio_000204
BSPBio_003479
GTPL205
KBioSS_000835
DivK1c_006919
SPBio_001814
SPBio_002143
LOXAPINE [ORANGE BOOK]
BPBio1_000226
BDBM22871
KBio1_001863
KBio2_000835
KBio2_003403
KBio2_005971
KBio3_002983
HMS5086L22
MSK10298
PXB45563
HY-17390R
PDSP1_001058
PDSP2_001042
s5197
AKOS030526111
CCG-204805
CS-1105
DB00408
SDCCGSBI-0050698.P003
QTL1_000050
NCGC00021145-01
NCGC00021145-02
NCGC00021145-03
NCGC00021145-04
NCGC00021145-05
NCGC00021145-06
NCGC00021145-07
NCGC00021145-08
NCGC00021145-23
NCGC00022279-03
NCGC00022279-04
NCGC00022279-05
HY-17390
MS-24900
NS00008936
C07104
D02340
F84888
Q58614
AB00053735_15
AB00053735_16
EN300-6479125
L001085
BRD-K39915878-036-04-6
BRD-K39915878-036-05-3
BRD-K39915878-036-15-2
BRD-K39915878-036-24-4
BRD-K39915878-036-25-1
2-Chloro-11-(4-methylpiperazino)dibenz[b,f][1,4]oxazepine
8-chloro-6-(4-methylpiperazino)benzo[b][1,4]benzoxazepine;succinic acid
13-chloro-10-(4-methylpiperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaene
13-chloro-10-(4-methylpiperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene
13-chloro-10-(4-methylpiperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,9,12,14-heptaene
Created AtJan 13, 2025 2:47 pm
Updated AtJan 13, 2025 2:47 pm